USA Financial Formulas’s AbbVie ABBV Stock Holding History

USA Financial Formulas’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$652	Hold	3	–	–	﹤0.01%	365
2025 Q4	$685	Buy	+3	New	+$683	﹤0.01%	339
2022 Q3	$3K	Sell	20 -5,219	-100%	-$749K	﹤0.01%	139
2022 Q2	$802K	Sell	5,239 -1,250	-19%	-$191K	1%	40
2022 Q1	$1.05M	Buy	6,489 +6,463	+24,858%	+$939K	1.13%	23
2021 Q4	$4K	Sell	26 -560	-96%	-$66.2K	﹤0.01%	224
2021 Q3	$63K	Buy	586 +102	+21%	+$11.7K	0.06%	178
2021 Q2	$55K	Buy	484 +459	+1,836%	+$51.7K	0.05%	208
2021 Q1	$3K	Sell	25 -754	-97%	-$80.7K	﹤0.01%	244
2020 Q4	$83K	Buy	+779	New	+$74.9K	0.07%	151
2018 Q4	–	Sell	-2,585	Closed	-$240K	–	316
2018 Q3	$240K	Sell	2,585 -31,475	-92%	-$2.98M	0.06%	243
2018 Q2	$3.22M	Sell	34,060 -258	-0.8%	-$25.2K	0.78%	55
2018 Q1	$3.25M	Sell	34,318 -4,945	-13%	-$543K	0.78%	55
2017 Q4	$3.8M	Buy	+39,263	New	+$3.7M	0.9%	44
2017 Q3	–	Sell	-5,887	Closed	-$427K	–	241
2017 Q2	$427K	Buy	5,887 +1,368	+30%	+$92K	0.1%	186
2017 Q1	$294K	Buy	4,519 +363	+9%	+$22.8K	0.07%	198
2016 Q4	$260K	Buy	+4,156	New	+$254K	0.06%	210
2016 Q3	–	Sell	-3,233	Closed	-$200K	–	219
2016 Q2	$200K	Buy	+3,233	New	+$197K	0.05%	203

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

USA Financial Formulas's ABBV Position: Q1 2026 in Review

USA Financial Formulas held its AbbVie (ABBV) position steady in Q1 2026 at 3 shares worth $652. The position accounts for ﹤0.01% of the portfolio, ranked #365.

USA Financial Formulas first reported a position in ABBV in Q2 2016 and has held it in 18 quarters since. The position peaked at $3.8M in Q4 2017. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

USA Financial Formulas held 3 shares of AbbVie worth $652 as of Q1 2026.
USA Financial Formulas left its AbbVie share count unchanged in Q1 2026.
AbbVie made up ﹤0.01% of USA Financial Formulas's portfolio in Q1 2026, its #365 holding.
USA Financial Formulas first reported a position in AbbVie in Q2 2016 and has held it in 18 quarters since.
USA Financial Formulas's AbbVie position peaked at $3.8M in Q4 2017.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.